| GM | gut microbiota |
| CLD | chronic liver disease |
| LC | liver cirrhosis |
| PEM | protein-energy-malnutrition |
| BCAA | branched-chain amino acid |
| HCC | hepatocellular carcinoma |
| SBP | spontaneous bacterial peritonitis |
| HE | hepatic encephalopathy |
| ACLF | acute on chronic liver failure |
| JSH | Japanese Society of Hepatology |
| CT | computed tomography |
| HCV | hepatitis C virus |
| PNALT | persistent normal alanine aminotransferase |
| COVID-19 | Coronavirus disease-19 |
| PAMPs | pathogen-associated molecular patterns |
| LPS | lipopolysaccharide |
| TLR | toll like receptor |
| NASH | non-alcoholic steatohepatitis |
| NAFLD | non-alcoholic fatty liver disease |
| HR | hazard ratio |
| CI | confidence interval |
| PPI | proton pump inhibitor |
| mTORC1 | mammalian target of rapamycin complex1 |
| TNF-α | tumor necrosis factor-alpha |
| CRC | colorectal cancer |
| SCFAs | short-chain fatty acids |
| HVPG | hepatic venous pressure gradient |
| TJ | tight junction |
| SIBO | small intestine bacterial overgrowth |
| BAs | bile acids |
| DCA | deoxycholic acid |
| RCT | randomized controlled trial |